Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 127.8x - 141.2x | 134.5x |
| Selected Fwd EBIT Multiple | -79.6x - -88.0x | -83.8x |
| Fair Value | ₩121.46 - ₩154.66 | ₩138.06 |
| Upside | -54.0% - -41.4% | -47.7% |
| Benchmarks | Ticker | Full Ticker |
| Icure Pharmaceutical Incorporation | A175250 | KOSDAQ:A175250 |
| HuM&C Co., Ltd. | A263920 | KOSDAQ:A263920 |
| HLscience Co., Ltd. | A239610 | KOSDAQ:A239610 |
| Outin Futures Co., Ltd | A227610 | KOSDAQ:A227610 |
| Hankook Cosmetics Co., Ltd. | A123690 | KOSE:A123690 |
| TS Trillion Co., Ltd. | A317240 | KOSDAQ:A317240 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| A175250 | A263920 | A239610 | A227610 | A123690 | A317240 | ||
| KOSDAQ:A175250 | KOSDAQ:A263920 | KOSDAQ:A239610 | KOSDAQ:A227610 | KOSE:A123690 | KOSDAQ:A317240 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | -43.3% | |
| 3Y CAGR | NM- | 217.5% | NM- | NM- | NM- | NM- | |
| Latest Twelve Months | 35.1% | -21.7% | -103.6% | -963.1% | 30.4% | -61.5% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | -35.7% | -11.3% | -8.8% | -21.0% | -6.1% | -4.0% | |
| Prior Fiscal Year | -48.8% | 14.1% | -18.9% | -1.0% | 3.7% | 1.8% | |
| Latest Fiscal Year | -26.0% | 11.3% | -55.8% | -9.9% | 4.0% | 0.9% | |
| Latest Twelve Months | -26.0% | 11.3% | -55.8% | -9.9% | 4.0% | 0.9% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.26x | 1.19x | 1.41x | 1.31x | 1.01x | 1.66x | |
| EV / LTM EBITDA | -9.5x | 8.0x | -3.4x | -28.4x | 16.8x | 32.6x | |
| EV / LTM EBIT | -4.8x | 10.5x | -2.5x | -13.3x | 25.1x | 187.3x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -13.3x | -2.5x | 25.1x | ||||
| Historical EV / LTM EBIT | -53.4x | -21.0x | 187.3x | ||||
| Selected EV / LTM EBIT | 127.8x | 134.5x | 141.2x | ||||
| (x) LTM EBIT | 273 | 273 | 273 | ||||
| (=) Implied Enterprise Value | 34,853 | 36,687 | 38,521 | ||||
| (-) Non-shareholder Claims * | (21,429) | (21,429) | (21,429) | ||||
| (=) Equity Value | 13,424 | 15,258 | 17,093 | ||||
| (/) Shares Outstanding | 110.5 | 110.5 | 110.5 | ||||
| Implied Value Range | 121.46 | 138.06 | 154.66 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 121.46 | 138.06 | 154.66 | 264.00 | |||
| Upside / (Downside) | -54.0% | -47.7% | -41.4% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A175250 | A263920 | A239610 | A227610 | A123690 | A317240 | |
| Enterprise Value | 87,238 | 56,141 | 24,895 | 45,363 | 94,075 | 50,606 | |
| (+) Cash & Short Term Investments | 22,437 | 6,180 | 26,868 | 8,129 | 16,336 | 4,807 | |
| (+) Investments & Other | 1,659 | 7 | 10,751 | 1,611 | 5,437 | 500 | |
| (-) Debt | (40,440) | (13,332) | (450) | (23,526) | (6,545) | (26,736) | |
| (-) Other Liabilities | (472) | 0 | (82) | 2,312 | (63) | 0 | |
| (-) Preferred Stock | (2,707) | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 67,714 | 48,996 | 61,981 | 33,889 | 109,241 | 29,178 | |
| (/) Shares Outstanding | 37.4 | 49.0 | 5.1 | 35.4 | 16.1 | 110.5 | |
| Implied Stock Price | 1,812.00 | 999.00 | 12,170.00 | 956.00 | 6,800.00 | 264.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,812.00 | 999.00 | 12,170.00 | 956.00 | 6,800.00 | 264.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |